These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 6668990)
1. The Markov process in medical prognosis. Beck JR; Pauker SG Med Decis Making; 1983; 3(4):419-458. PubMed ID: 6668990 [TBL] [Abstract][Full Text] [Related]
2. Use of Markov series and Monte Carlo simulation in predicting replacement valve performances. de Kruyk AR; van der Meulen JH; van Herwerden LA; Bekkers JA; Steyerberg EW; Dekker R; Habbema JD J Heart Valve Dis; 1998 Jan; 7(1):4-12. PubMed ID: 9502132 [TBL] [Abstract][Full Text] [Related]
3. Markov models in medical decision making: a practical guide. Sonnenberg FA; Beck JR Med Decis Making; 1993; 13(4):322-38. PubMed ID: 8246705 [TBL] [Abstract][Full Text] [Related]
4. [Decision analysis in radiology using Markov models]. Golder W Rofo; 2000 Jan; 172(1):80-5. PubMed ID: 10719468 [TBL] [Abstract][Full Text] [Related]
5. Quality-adjusted life expectancy (QALE) and loss of QALE for patients with ischemic stroke and intracerebral hemorrhage: a 13-year follow-up. Lee HY; Hwang JS; Jeng JS; Wang JD Stroke; 2010 Apr; 41(4):739-44. PubMed ID: 20150543 [TBL] [Abstract][Full Text] [Related]
6. Laparotomy versus no laparotomy in the management of early-stage, favorable-prognosis Hodgkin's disease: a decision analysis. Ng AK; Weeks JC; Mauch PM; Kuntz KM J Clin Oncol; 1999 Jan; 17(1):241-52. PubMed ID: 10458239 [TBL] [Abstract][Full Text] [Related]
7. Decision analysis on alternative treatment strategies for favorable-prognosis, early-stage Hodgkin's disease. Ng AK; Weeks JC; Mauch PM; Kuntz KM J Clin Oncol; 1999 Nov; 17(11):3577-85. PubMed ID: 10550157 [TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in patients with atrial fibrillation and prior stroke or transient ischemic attack. Kamel H; Johnston SC; Easton JD; Kim AS Stroke; 2012 Mar; 43(3):881-3. PubMed ID: 22308255 [TBL] [Abstract][Full Text] [Related]
9. Prognosis in SLE: comparison of Markov model to life table analysis. Silverstein MD; Albert DA; Hadler NM; Ropes MW J Clin Epidemiol; 1988; 41(7):623-33. PubMed ID: 3397759 [TBL] [Abstract][Full Text] [Related]
10. Decision analysis of tamoxifen for the prevention of invasive breast cancer. Grann VR; Sundararajan V; Jacobson JS; Whang W; Heitjan DF; Antman KH; Neugut AI Cancer J; 2000; 6(3):169-78. PubMed ID: 10882333 [TBL] [Abstract][Full Text] [Related]
11. Stereotactic body radiotherapy versus surgery for medically operable Stage I non-small-cell lung cancer: a Markov model-based decision analysis. Louie AV; Rodrigues G; Hannouf M; Zaric GS; Palma DA; Cao JQ; Yaremko BP; Malthaner R; Mocanu JD Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):964-73. PubMed ID: 20932688 [TBL] [Abstract][Full Text] [Related]
12. Patient outcome after aortic valve replacement with a mechanical or biological prosthesis: weighing lifetime anticoagulant-related event risk against reoperation risk. van Geldorp MW; Eric Jamieson WR; Kappetein AP; Ye J; Fradet GJ; Eijkemans MJ; Grunkemeier GL; Bogers AJ; Takkenberg JJ J Thorac Cardiovasc Surg; 2009 Apr; 137(4):881-6, 886e1-5. PubMed ID: 19327512 [TBL] [Abstract][Full Text] [Related]
13. Probabilistic analysis of decision trees using Monte Carlo simulation. Critchfield GC; Willard KE Med Decis Making; 1986; 6(2):85-92. PubMed ID: 3702625 [TBL] [Abstract][Full Text] [Related]
14. A radiobiological Markov simulation tool for aiding decision making in proton therapy referral. Austin AM; Douglass MJJ; Nguyen GT; Penfold SN Phys Med; 2017 Dec; 44():72-82. PubMed ID: 29254594 [TBL] [Abstract][Full Text] [Related]
15. Long-term medical costs and life expectancy of acute myeloid leukemia: a probabilistic decision model. Wang HI; Aas E; Howell D; Roman E; Patmore R; Jack A; Smith A Value Health; 2014 Mar; 17(2):205-14. PubMed ID: 24636378 [TBL] [Abstract][Full Text] [Related]
16. Using the 21-gene assay to guide adjuvant chemotherapy decision-making in early-stage breast cancer: a cost-effectiveness evaluation in the German setting. Blohmer JU; Rezai M; Kümmel S; Kühn T; Warm M; Friedrichs K; Benkow A; Valentine WJ; Eiermann W J Med Econ; 2013; 16(1):30-40. PubMed ID: 22966753 [TBL] [Abstract][Full Text] [Related]
17. Transcatheter aortic valve replacement in nonsurgical candidates with severe, symptomatic aortic stenosis: a cost-effectiveness analysis. Simons CT; Cipriano LE; Shah RU; Garber AM; Owens DK; Hlatky MA Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):419-28. PubMed ID: 23838104 [TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma. Cucchetti A; Piscaglia F; Cescon M; Colecchia A; Ercolani G; Bolondi L; Pinna AD J Hepatol; 2013 Aug; 59(2):300-7. PubMed ID: 23603669 [TBL] [Abstract][Full Text] [Related]
19. Use of colonic stents in emergent malignant left colonic obstruction: a Markov chain Monte Carlo decision analysis. Govindarajan A; Naimark D; Coburn NG; Smith AJ; Law CH Dis Colon Rectum; 2007 Nov; 50(11):1811-24. PubMed ID: 17899279 [TBL] [Abstract][Full Text] [Related]
20. The half-cycle correction: banish rather than explain it. Barendregt JJ Med Decis Making; 2009; 29(4):500-2. PubMed ID: 19571330 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]